Diuretic use in renal disease (Q37969997)

26 August 2017

title

Diuretic use in renal disease (English)

1 reference

26 August 2017

Domenic A Sica

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

Nature Reviews Nephrology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

100-109

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Pharmacokinetics/pharmacodynamics of furosemide in man: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Long-term adaptation of renal ion transporters to chronic diuretic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Aspects on pharmacokinetics of some diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Comparison of loop diuretics in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Pharmacokinetics of loop diuretics in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Drug-induced cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic drugs and the treatment of edema: from clinic to bench and back again

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The physiologic basis of diuretic synergism: its role in treating diuretic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Electrolyte changes during craniotomy caused by administration of hypertonic mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Role of excess volume in the pathophysiology of hypertension in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The risks and benefits of aldosterone antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Eplerenone: a new aldosterone receptor antagonist--are the FDAs restrictions appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Metolazone and its role in edema management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious Than Bolus Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Vasopressin and aquaporin 2 in clinical disorders of water homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The influence of the extracellular fluid volume on the tubular reabsorption of uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Uric acid: bystander or culprit in hypertension and progressive renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Uric acid transport and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The Evidence-Based Use of Thiazide Diuretics in Hypertension and Nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Ethacrynic acid and the sulfa-sensitive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic strategies in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Loop diuretics: from the Na-K-2Cl transporter to clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Response of the kidney to furosemide. II. Effect of captopril on sodium balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Mechanism of impaired natriuretic response to furosemide during prolonged therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Mannitol-induced acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Sequential nephron blockade breaks resistance to diuretics in edematous states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

High Dosage Metolazone in Chronic Renal Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Role of aldosterone in the sodium retention of patients with nephrotic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Synergistic action of metolazone with "loop" diuretics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Hypokalaemia and diuretics: an analysis of publications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Effects of bendroflumethiazide on urate metabolism during treatment of patients with renal stones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Thiazide-induced photosensitivity: a study of 33 subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.175

Ototoxicity of loop diuretics.

31 March 2020

1 reference

12 December 2020

Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome

1 reference

12 December 2020

Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate

1 reference

12 December 2020

A volume-independent component to postdiuretic sodium retention in humans

1 reference

12 December 2020

Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.

1 reference

12 December 2020

Variable furosemide absorption and poor predictability of response in elderly patients.

1 reference

12 December 2020

Response of the kidney to furosemide. I. Effects of salt intake and renal compensation

1 reference

12 December 2020

Aspects on pharmacokinetics of some diuretics

1 reference

12 December 2020

Diuretic use in stage 5 chronic kidney disease and end-stage renal disease

1 reference

12 December 2020

Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion

1 reference

12 December 2020

Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats

1 reference

12 December 2020

Volaemia and blood pressure in renal failure: have old truths been forgotten?

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

Diuretics in congestive heart failure

1 reference

12 December 2020

Facilitation by serum albumin of renal tubular secretion of organic anions

1 reference

12 December 2020

New insights into diuretic use in patients with chronic renal disease.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.175

1 reference

Dimensions Publication ID

26 August 2017

1022077445

0 references

1 reference